Toshifusa Nakajima Selected Research

Toshifusa Nakajima Research Topics

Disease

18	Stomach Neoplasms (Stomach Cancer) 05/2018 - 01/2002
11	Neoplasms (Cancer) 01/2017 - 01/2002
4	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 11/2013
4	Neutropenia 01/2015 - 01/2004
3	Rectal Neoplasms (Rectal Cancer) 01/2019 - 01/2015
3	Carcinoma (Carcinomatosis) 01/2019 - 06/2013
2	Diarrhea 05/2004 - 01/2004
1	Vomiting 05/2018
1	Adenoma (Adenomas) 06/2013
1	Cicatrix (Scar) 06/2013
1	Adenocarcinoma 06/2013
1	Heart Diseases (Heart Disease) 10/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2012
1	Overweight 12/2009
1	Neoplasm Metastasis (Metastasis) 05/2009
1	Lymphatic Metastasis 05/2004
1	Nausea 01/2004
1	Fatigue 01/2004
1	Leukopenia 01/2004
1	Anorexia 01/2004
1	Stomatitis 01/2004
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2002

Drug/Important Bio-Agent (IBA)

6	Fluorouracil (Carac)FDA LinkGeneric 09/2014 - 06/2003
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 09/2014
5	Cisplatin (Platino)FDA LinkGeneric 05/2018 - 05/2004
3	Cetuximab (Erbitux)FDA Link 01/2017 - 01/2016
3	Pharmaceutical PreparationsIBA 04/2016 - 10/2012
2	Trastuzumab (Herceptin)FDA Link 05/2018 - 01/2018
2	S-1 plus cisplatinIBA 05/2018 - 02/2014
2	Leucovorin (Folinic Acid)FDA Link 09/2014 - 11/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2013 - 05/2004
1	Biological ProductsIBA 01/2016
1	LigandsIBA 01/2016
1	EpiregulinIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	AmphiregulinIBA 01/2016
1	Capecitabine (Xeloda)FDA Link 09/2014
1	Drug CombinationsIBA 09/2014
1	Epirubicin (Ellence)FDA LinkGeneric 09/2014
1	PlatinumIBA 02/2014
1	Platinum Compounds (Compounds, Platinum)IBA 02/2014
1	Docetaxel (Taxotere)FDA Link 02/2014
1	Bevacizumab (Avastin)FDA Link 11/2013
1	titanium silicide (TS-1)IBA 10/2013
1	Gemcitabine FDA Link 05/2012
1	S 1 (combination)IBA 05/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2011
1	Pepsinogen A (Pepsinogen)IBA 04/2011
1	Proteins (Proteins, Gene)FDA Link 04/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011
1	tegafur-gimeracil-oteracilIBA 01/2004
1	BilirubinIBA 01/2004
1	PotassiumIBA 01/2004
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/2003
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2003
1	Asialoglycoprotein ReceptorIBA 11/2002

Therapy/Procedure

10	Adjuvant Chemotherapy 04/2016 - 01/2002
7	Drug Therapy (Chemotherapy) 01/2017 - 06/2003
6	Gastrectomy 06/2013 - 01/2004
5	Lymph Node Excision (Lymph Node Dissection) 11/2011 - 01/2002
4	Chemoradiotherapy 01/2019 - 09/2014
4	Therapeutics 10/2013 - 05/2004
1	FPEPIR regimen 09/2014
1	Radiotherapy 09/2014
1	Operative Surgical Procedures 12/2009